Source / Anaesthetic instrument
A surviving glass inhaler associated with dentist William T. G. Morton shows how liquid ether was turned into an inhalable vapour during the rapid spread of surgical anaesthesia in 1846.
The instrument made pain relief appear controllable and repeatable, but it also exposes uncertain dosage, disputed credit, commercial ambition, and the difference between a preserved object and the famous demonstration it represents.
Reading the object
Ether could produce insensibility without this particular device, but an inhaler promised a bounded path from liquid chemical to patient. Glass made the contents visible, while openings and a mouthpiece directed air and vapour.
Ether evaporated from material inside the vessel as air passed through it. The patient inhaled the resulting mixture. Yet concentration changed with temperature, airflow, liquid quantity, breathing, leaks, and duration. The object offered practical control without the calibrated delivery and physiological monitoring expected in later anaesthesia.
Morton had used ether for dental extraction before bringing it to Massachusetts General Hospital on 16 October 1846. Surgeon John Collins Warren removed a neck tumour from Gilbert Abbott while Morton administered vapour. The operation's institutional audience helped turn anaesthesia into international news.
The Smithsonian record identifies this instrument as supplied to another Boston dentist later in 1846. Its inscription calls it the only complete Morton inhaler known to survive. It documents early replication after the demonstration rather than providing direct material contact with Abbott's operation.
Credit and risk
Crawford Long had used ether during operations in Georgia from 1842 but published later. Horace Wells promoted nitrous oxide, and Charles Jackson disputed Morton's claims. Surgical pain relief emerged from chemistry, recreational inhalation, dentistry, earlier experiments, patient participation, and institutional publicity rather than a single isolated invention.
Morton initially called his agent “Letheon” and sought financial control before ether's identity became public. The inhaler therefore belongs to the history of patents, secrecy, professional reputation, and markets as well as humanitarian relief. Apparatus could make a technique look proprietary even when the drug and relevant knowledge circulated more widely.
Ether was flammable and could obstruct breathing, provoke vomiting, or produce dangerous overdose. Successful insensibility did not itself create safe anaesthesia. Airways, dosage, observation, recovery, trained anaesthetists, and later monitoring technologies gradually turned a dramatic demonstration into a specialised system of care.
Across the collection
Place the Boston demonstration within dentistry, surgery, publicity, replication, and contested priority.
Trace gases, inhalers, intravenous drugs, airway management, monitoring, professional roles, and safety.
Compare how devices mediate skill, standardise procedures, create evidence, and redistribute authority.